Attending to External Cues and Movement Strategies in Parkinson Disease
1 other identifier
interventional
15
1 country
1
Brief Summary
People with Parkinson's disease use compensatory strategies to overcome typical gait disturbances. These strategies rely on attentional mechanisms, however people with Parkinson disease suffer of decline in cognitive function. Therefore, the current study aims at exploring brain engagement and focus of attention process during walking with these compensatory strategies, in people with Parkinson disease. Such exploration would assist in understanding the feasibility of the compensatory strategies in daily lives of people with Parkinson's disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable parkinson-disease
Started Mar 2019
Typical duration for not_applicable parkinson-disease
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 30, 2020
CompletedFirst Submitted
Initial submission to the registry
September 1, 2020
CompletedFirst Posted
Study publicly available on registry
December 19, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
August 30, 2021
CompletedJanuary 4, 2022
January 1, 2022
1.5 years
September 1, 2020
January 2, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Gait speed- Physiological measurement of gait
Gait speed is measured with the Mobility Lab OPAL system (APDM, USA) consisting of three small inertial measurement units (IMU sensors including 3D accelerometers and 3D gyroscopes sampled at 128 Hz, MobilityLab, APDM Inc., Portland, OR). IMUs were attached at the participant's ankles, and lumbar region using elastic Velcro straps. These sensors are measuring gait speed (meters per second).
Through study completion, an average of 1 year
Step length- Physiological measurement of gait
Step length is measured with the Mobility Lab OPAL system (APDM, USA) consisting of three small inertial measurement units (IMU sensors including 3D accelerometers and 3D gyroscopes sampled at 128 Hz, MobilityLab, APDM Inc., Portland, OR). IMUs were attached at the participant's ankles, and lumbar region using elastic Velcro straps. These sensors are measuring step length (cm).
Through study completion, an average of 1 year
Cadence- Physiological measurement of gait
Cadence is measured with the Mobility Lab OPAL system (APDM, USA) consisting of three small inertial measurement units (IMU sensors including 3D accelerometers and 3D gyroscopes sampled at 128 Hz, MobilityLab, APDM Inc., Portland, OR). IMUs were attached at the participant's ankles, and lumbar region using elastic Velcro straps.These sensors are measuring cadence (number of steps taken in 1 minute).
Through study completion, an average of 1 year
Swing time percent- Physiological measurement of gait
Swing time percent (the percent of time from the total time of one gait cycle that one leg is in the air is measured with the Mobility Lab OPAL system (APDM, USA) consisting of three small inertial measurement units (IMU sensors including 3D accelerometers and 3D gyroscopes sampled at 128 Hz, MobilityLab, APDM Inc., Portland, OR). IMUs were attached at the participant's ankles, and lumbar region using elastic Velcro straps.These sensors are measuring swing time percent (unit are given in percents)
Through study completion, an average of 1 year
Electrical activity (eeg) of the brain-phisyological measure of electircal signals
During the walking, measure of attention recruitment during walking is applied by a single-channel EEG system (Brain-MARC LTD). The system simplifies EEG analysis to adjust the extraction of relevant attention-related markers from ongoing EEG. EEG is sampled using the MindWave dry electrode system \[25\], with one frontal electrode (∼Fpz) and one reference electrode on the earlobe. The sampled data are transferred through a wireless connection to the experiment computer, where the signal is processed. An algorithm is calaculating
Through study completion, an average of 1 year
Secondary Outcomes (10)
Cognitive function Go-NoGo Response Inhibition
Through study completion, an average of 1 year
Cognitive function-Stroop Interference
Through study completion, an average of 1 year
Cognitive function-Staged Information Processing Speed
Through study completion, an average of 1 year
Cognitive function-Finger Tapping
Through study completion, an average of 1 year
Cognitive function-'Catch' Game
Through study completion, an average of 1 year
- +5 more secondary outcomes
Study Arms (1)
Brain engagement while using compesatory modes for walking
EXPERIMENTALBrain engagemnent (recruitment of attention) is measured during four walking conditions
Interventions
external cueing are sensory stimuli such as auditory (e.g. rhythmic metronome beats) or or visual (e.g. spaced lines on the floor). Cognitive movement strategies refer to focusing attention on a specific parameter of gait (e.g. step length, arm swing). In the study participants walk under four walking conditions:1)usuall (baseline) walking 2)walking while attending to external cues wich will be applied via metronome beats. The number of beats per minute is adjusted to each participant's steps number per minute. 3)walking with movement cognitive strategy: participants are requested to focus on their step length- and focus on increasing their step length while walking 4) Dual tasking-walking while performing a cognitive task. During the four walking conditions Brain engegament will be measured, using the single-channel EEG system (Brain-MARC LTD) described in the follwing outcomes measures section.
Eligibility Criteria
You may qualify if:
- Diagnosis of Parkinson's disease
- Age of 50-85
- Able to walk independently in daily lives.
- Age of 50-85
- Able to walk independently in daily lives.
You may not qualify if:
- Use of assistive hearing device
- Suffer of hearing impairment (by self-declaration)
- Suffer of dementia (MoCa test score above 21)
- Suffer of any orthopedic condition
- Pains or other health condition that may affect gait except of PD
- Use of assistive hearing device
- Suffer of hearing impairment (by self-declaration)
- Suffer of dementia (MoCa test score above 21)
- Suffer of any orthopedic condition
- Pains or other health condition that may affect gait
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Galit Yogev-Seligmann
Haifa, Please Select..., 3498838, Israel
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Galit Yogev-Seligmann
University of Haifa
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Prinicipal Investigator
Study Record Dates
First Submitted
September 1, 2020
First Posted
December 19, 2020
Study Start
March 1, 2019
Primary Completion
August 30, 2020
Study Completion
August 30, 2021
Last Updated
January 4, 2022
Record last verified: 2022-01
Data Sharing
- IPD Sharing
- Will not share